{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-030443","form_type":"8-K","ticker":"MOVE","cik":"0001734750","company_name":"Corvex, Inc.","filed_at":"2024-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.808640+00:00","generated_at":"2026-06-04T02:23:26.496699+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Movano Health raises $24M, reports Q4 operating loss of $6.0M, achieves FDA accuracy milestone","bullets":["Executed $24M private placement including $3.0M from a tier-1 medical device company and $3.6M from insiders.","Q4 2023 operating loss of $6.0M, improved from $8.0M loss in Q4 2022.","Second hypoxia trial: Evie Ring pulse oximeter RMSE 2.46% (FDA guideline 3.5%), exceeding two hospital-grade reference devices.","Ended 2023 with $6.1M cash; new financing extends runway for Evie Med FDA submission and B2B strategy.","Launched Evie Ring in Nov 2023; revenue recognition begins in 2024 as shipments started Jan 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-030443","json":"https://secwatch.observer/filing/0001213900-24-030443.json","markdown":"https://secwatch.observer/filing/0001213900-24-030443.md","text":"https://secwatch.observer/filing/0001213900-24-030443.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1734750/000121390024030443/0001213900-24-030443-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1734750/000121390024030443/ea0203275-8k_movano.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T02:23:26.496699+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ce5089dddedbf5f8d5fa39ce6653093201a59b6d","claim":"Corvex, Inc. reported financial results for the quarter and year ended December 31, 2023.","evidence_excerpt":"Movano Inc. announced its financial results for the quarter and year ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1734750/000121390024030443/0001213900-24-030443-index.htm","confidence":0.7,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter and year ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}